Kirsten E. Smith, Ph.D. is a postdoctoral research fellow at the National Institute on Drug Abuse Intramural Research Program (NIDA IRP)working in the Translational Addiction Medicine Branch. Dr. Smith has been investigating real-world instances of kratom use since 2017. At NIDA IRP, she recently completed a national ecological momentary assessment study of daily kratom use and an observational laboratory study on the effects of commercial kratom products among those who use regularly. She will be continuing her kratom research at the Johns Hopkins University Behavioral PharmacologyResearch Unit as Assistant Professor beginning in August 2023.
Jack E. Henningfield, PhD, Professor,Adjunct, Dept.Psychiatry & Behavioral Sciences, Johns Hopkins University, and VicePresident, Research, Health Policy & Abuse Liability, PinneyAssociates. Former, Chief Clinical Pharmacology Branch & Biology of Dependence &Abuse Potential Section, National Institute on Drug Abuse (NIDA). I have 52years in preclinical & clinical abuse/dependence potential research. Most of my approximately 500 publications and reports for NIDA & the WorldHealth Organization involved abuse/dependence potential across a broad range ofCNS active substances and new drugs.
Dr. Marilyn Huestis was the former Chief of Chemistry and Drug Metabolism at the National Institute of Health’s National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) where she conducted controlled drug administration studies. She is a toxicologist studying the effects of illicit drugs and licit pharmacotherapies on cognition, physiology, motor control, and in utero. Her current research interests are on cannabinoid agonists and antagonists, mitragynine, psilocybin, the neurobiology of novel psychoactive substances, effects of drugs on human performance, in utero drug exposure, and the analysis of drugs and metabolites in a wide variety of biological fluids and tissues. Her doctoral research focused on cannabis(marijuana), and she went on to study a wide range of illicit drugs, including cocaine, methamphetamine, ecstasy, and heroin and methadone and buprenorphine. Dr. Huestis served on the National Commission on Forensic Sciences, was president of the Society of Forensic Toxicologists, Chair of the Toxicology Section of the American Academy of Forensic Sciences, and president of The InternationalAssociation of Forensic Toxicologists.
Christopher R. McCurdy, Ph.D., FAAPS, is a broadly trained medicinal chemist, behavioral pharmacologist and pharmacist whose research focuses on the design, synthesis and development of drugs to treat pain and drug abuse. For over 20 years, much of his research has focused on opioid, Neuropeptide FF and sigma receptor ligand/probe design, synthesis, pharmacological evaluation and development. He has been successful in discovering unique and selective tools for sigma receptors, NPFF receptors and opioid receptors. He is an internationally recognized expert on Kratom(Mitragyna speciosa), that is under investigation for opioid withdrawal syndrome.